Xiaoxiang Guan, Yehui Shi, Jin Yang, Fei Xu, Huihui Li, Wenhui Wang, Xinhong Wu, Xin Zhou, Yunjiang Liu, Haijun Yu, Wenhui Guo, Huoling Tang, Xiangzhu Tian, Yuhong Zhou, Ziping Wei. "A phase II study to evaluate the safety and efficacy of BB-1701 in subjects with HER2 expression locally advanced/metastatic breast cancer previously treated with HER2-ADC containing TOP-I inhibitor.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.1093